KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Change in Receivables: 2009-2024

Historic Change in Receivables for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to $2.4 million.

  • Dynavax Technologies' Change in Receivables fell 100.19% to -$24,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.0 million, marking a year-over-year decrease of 106.88%. This contributed to the annual value of $2.4 million for FY2024, which is 105.48% up from last year.
  • Per Dynavax Technologies' latest filing, its Change in Receivables stood at $2.4 million for FY2024, which was up 105.48% from -$43.3 million recorded in FY2023.
  • Dynavax Technologies' 5-year Change in Receivables high stood at $109.2 million for FY2021, and its period low was -$43.3 million during FY2023.
  • Its 3-year average for Change in Receivables is -$8.4 million, with a median of $2.4 million in 2024.
  • Its Change in Receivables has fluctuated over the past 5 years, first soared by 692.41% in 2021, then tumbled by 375.61% in 2023.
  • Over the past 5 years, Dynavax Technologies' Change in Receivables (Yearly) stood at $13.8 million in 2020, then surged by 692.41% to $109.2 million in 2021, then plummeted by 85.62% to $15.7 million in 2022, then plummeted by 375.61% to -$43.3 million in 2023, then soared by 105.48% to $2.4 million in 2024.